QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

IART

QT76Integra LifeSciences Holdings Corporation
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
17.58
+0.38+2.21%
OverviewShort InterestFilings
IARTQT76Integra LifeSciences Holdings Corporation·NASDAQ
OverviewShort InterestFilings
17.58+2.21%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-6.48
Insider Own17.32%
Shs Outstand77.80M
Perf Week0.40%
Market Cap1.34BForward P/E6.73EPS next Y2.61Insider Trans0.06%Shs Float-Perf Month22.25%
Enterprise Value3.14BPEG0.00EPS next Q0.49Inst Own-Short Float-Perf Quarter97.53%
Income-501254782.00P/S0.81EPS this Y137.63%Inst Trans-Short Ratio-Perf Half Y35.23%
Sales1.64BP/B1.27EPS next Y7.06%ROA-13.86%Short Interest-Perf YTD41.55%
Book/sh13.39P/C18.53EPS next 5Y8.34%ROE-47.65%52W High18.30 -3.93%Perf Year44.69%
Cash/sh3.42P/FCF-EPS past 3/5Y-ROIC3.49%52W Low8.70 102.07%Perf 3Y-
Dividend Est.-EV/EBITDA-10.86Sales past 3/5Y1.62% 3.57%Gross Margin53.21%Volatility3.22% 3.29%Perf 5Y-
Dividend TTM-EV/Sales1.91EPS Y/Y TTM2716.41%Oper. Margin7.53%ATR (14)0.84Perf 10Y-
Dividend Ex-Date-Quick Ratio1.95Sales Y/Y TTM2.11%Profit Margin-30.15%RSI (14)63.56Recom2.73
Dividend Gr. 3/5Y-Current Ratio3.38EPS Q/Q31.71%SMA205.82%Beta2.09Target Price18.50
Payout0.00%Debt/Eq1.96Sales Q/Q2.35%SMA5026.83%Rel Volume2.27Prev Close17.20
Employees4,396LT Debt/Eq1.81EarningsJul 30SMA20037.58%Avg Volume1.02MPrice17.58
IPO DateAug 16, 1995Option/ShortYes / YesEPS/Sales Surpr.31.71% 2.62%Net Debt/EBITDA-6.23Volume2,322,858Change2.21%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-18-26ReiteratedArgus ResearchHold$25
May-28-26UpgradeCitigroupSell → Neutral
Apr-15-26ReiteratedTruist Financial$13 → $12
Apr-15-26DowngradeArgus ResearchBuy → Hold
Oct-15-25ReiteratedTruist Financial$13 → $15
Mar-31-25UpgradeArgus ResearchHold → Buy
Oct-07-24UpgradeBTIGSell → Neutral$22 → $20
Jul-30-24ReiteratedTruist Financial$32 → $26
Jul-30-24DowngradeCitigroupNeutral → Sell$23
Jul-30-24DowngradeBTIGNeutral → Sell$22
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,6451,6351,611
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A770790728
Gross Profit874845882
Selling, General and Administrative Excl. Other696700717
Research and Development9899115
Other Operating Expense-43-2222
Operating Income1236828
Interest Expense958671
Unusual Expense
———
Non-Operating Income (Expense)565546-24
Net Income Before Taxes-536-564-18
Income Taxes-40-47-11
Consolidated Net Income-496-516-7
Net Income From Continuing Operations-496-516-7
Net Income-496-516-7
EPS (Recurring)-6.48-6.73-0.09
EPS (Basic, Before Extraordinaries)-6.48-6.73-0.09
EPS (Diluted)-6.48-6.73-0.09
EBITDA-289-326193
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.820.58—
Gross Margin53.1351.6854.75
Operating Margin7.484.161.74
Net Margin-30.15-31.56-0.43
Shares Outstanding777777
Market Capitalization1,354956—
Operating Lease Expense
———
Insider Trading Volume
$19.18$17.55$15.91$14.28$12.65● Close Price0.00K25.54K51.08K76.61K102.15KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 11 '26Option Exercise0.0037,844040,612Mar 12 12:00 AM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '26Option Exercise0.002,432023,152Mar 12 12:00 AM
Poul MojdehPresident & CEOJan 06 '26Option Exercise0.002,7800102,840Jan 07 12:00 AM
GRAVES JEFFREY ADirectorNov 05 '25Buy11.359,000102,15041,086Nov 06 12:00 AM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALOct 12 '25Option Exercise0.0023,930025,217Oct 14 12:00 AM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 11 '25Option Exercise0.004,712034,531Mar 13 12:00 AM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '25Option Exercise0.002,360036,887Mar 11 12:00 AM
Schwartz EricEVP, Chief Legal Officer & SecDec 03 '24Sale24.594,070100,10259,511Dec 04 12:00 AM
McBreen Michael J.EVP & President, CSSDec 02 '24Sale24.161,70041,06456,182Dec 03 12:00 AM
De Witte JanPresident & CEONov 01 '24Option Exercise0.0019,6280120,466Nov 04 12:00 AM
Mosebrook JeffreySVP, Fin & Princ Acct OfficerAug 19 '24Sale21.581,19125,70136,088Aug 20 12:00 AM
ESSIG STUARTExec. Chairman of the BoardMay 23 '24Buy28.4952,6411,499,979487,922May 24 12:00 AM
HILL BARBARA BDirectorMay 21 '24Buy27.4036,350995,81636,350May 22 12:00 AM
De Witte JanPresident & CEOMar 11 '24Option Exercise0.004100130,280Mar 13 12:00 AM
De Witte JanPresident & CEOMar 10 '24Option Exercise0.00692089,071Mar 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR